Synlogic's Series A - II Round

Synlogic raised a round of funding on October 07, 2014. Investors include Bill & Melinda Gates Foundation.

Synlogic is a biotechnology company focusing on delivering the potential of next generation synthetic biology to patients. Synlogic is pioneering the development of a novel class of living medicines, …

Articles about Synlogic's Series A - II Round: